titlesubmit dateissue date
Now showing items 1-8 of 8
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
Role of Beta-blockers in Cardiovascular Disease in 2019
The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure
Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes